Clinical Trials Browser

Withdrawn × olaparib × Dermatologic × Clear all

NCT05482074 2024-01-19

Olaparib in Unresectable/Metastatic Melanoma With BRCA1/2

Phase 2 Withdrawn

Uveal Melanoma, Melanoma